share_log

Morgan Stanley Maintains Underweight on Embecta, Lowers Price Target to $16

Benzinga ·  Aug 24, 2023 09:32

Morgan Stanley analyst Cecilia Furlong maintains Embecta (NASDAQ:EMBC) with a Underweight and lowers the price target from $19 to $16.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment